LYNN FAIRCHILD: Open Payments
NPI 1366403107 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 34 payments from 15 companies in 2025. Trend: 2023 $1,146 · 2024 $1,288 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $154 |
| Galderma Laboratories, L.P. | 4 | $107 |
| LEO Pharma Inc. | 4 | $94 |
| Janssen Biotech, Inc. | 3 | $85 |
| UCB, Inc. | 3 | $83 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $29 |
| Incyte Corporation | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: CIBINQO, NEMLUVIO, ADBRY, TREMFYA, Bimzelx, ILUMYA, SKYRIZI, TALTZ.
Industry payments across CT — which companies pay providers there.
